Medications for Renal Stone Treatment

Stone-Specific Pharmacological Management

• The American Urological Association recommends thiazide diuretics for patients with recurrent calcium stones, particularly those with hypercalciuria 1
• Potassium citrate is indicated for patients with low urinary citrate or those with persistent stone formation despite addressing other metabolic abnormalities, as recommended by the American Urological Association 1
• Allopurinol should be offered to patients with recurrent calcium oxalate stones who have hyperuricosuria and normal urinary calcium, according to the American Urological Association 1
• The American Urological Association suggests that combination therapy with thiazides and potassium citrate may be necessary for patients with persistent stone formation 2
• Potassium citrate is the first-line therapy for uric acid stones to raise urinary pH to approximately 6.0, as recommended by the American Urological Association 1
• Allopurinol should not be routinely offered as first-line therapy for uric acid stones as most patients have low urinary pH rather than hyperuricosuria as the predominant risk factor, according to the American Urological Association 1
• Potassium citrate should be offered to raise urinary pH to approximately 7.0 for patients with cystine stones, as recommended by the American Urological Association 1
• Cystine-binding thiol drugs, such as alpha-mercaptopropionylglycine (tiopronin), should be offered to patients unresponsive to dietary modifications and urinary alkalinization, according to the American Urological Association 1
• Tiopronin is preferred over d-penicillamine due to better efficacy and fewer adverse events, as recommended by the American Urological Association 1
• Urease inhibitors (acetohydroxamic acid or AHA) may be beneficial for patients with struvite stones, though side effects may limit use, according to the American Urological Association 1

Medication Dosing and Considerations

• Potassium citrate is preferred over sodium citrate, as sodium load may increase urine calcium excretion, as recommended by the American Urological Association 1

Monitoring and Follow-up

• Obtain a 24-hour urine specimen within six months of initiating treatment to assess response to therapy, as recommended by the American Urological Association 1
• Annual 24-hour urine collections are recommended for ongoing monitoring, with more frequent testing depending on stone activity, according to the American Urological Association 1

Common Pitfalls and Caveats

• Inadequate fluid intake remains a major risk factor for stone recurrence regardless of pharmacological intervention, as noted by the American Urological Association 2
• Dietary calcium restriction should be avoided as it can worsen stone formation, as recommended by the American Urological Association 2
• Combination therapy may be necessary for patients with multiple metabolic abnormalities, according to the American Urological Association 1, 2